Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1590-3478
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence ; day:10 ; month:5 ; year:2022 ; pages:1-8
Neurological sciences ; (10.5.2022), 1-8
- Creator
-
Liguori, Claudio
Fernandes, Mariana
Cerroni, Rocco
Ludovisi, Raffaella
Mercuri, Nicola Biagio
Stefani, Alessandro
Pierantozzi, Mariangela
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-022-06111-x
- URN
-
urn:nbn:de:101:1-2022071621460142478200
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liguori, Claudio
- Fernandes, Mariana
- Cerroni, Rocco
- Ludovisi, Raffaella
- Mercuri, Nicola Biagio
- Stefani, Alessandro
- Pierantozzi, Mariangela
- SpringerLink (Online service)
Other Objects (12)
Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Neurokinin Concentrations in Cerebrospinal Fluid. A Preliminary Study in Parkinson’s Disease
Camptocormia due to myotinilopathy, Parkinson’s disease, or both? : Camptocormia and axial myopathy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Parkinson’s disease tremor prediction using EEG data analysis-A preliminary and feasibility study
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Neurokinin Concentrations in Cerebrospinal Fluid. A Preliminary Study in Parkinson’s Disease
Camptocormia due to myotinilopathy, Parkinson’s disease, or both? : Camptocormia and axial myopathy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Parkinson’s disease tremor prediction using EEG data analysis-A preliminary and feasibility study
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
Reply to: Camptocormia due to myotinilopathy, Parkinson’s disease, or both?
Neurokinin Concentrations in Cerebrospinal Fluid. A Preliminary Study in Parkinson’s Disease
Camptocormia due to myotinilopathy, Parkinson’s disease, or both? : Camptocormia and axial myopathy
Comparison of once-daily versus twice-daily combination of Ropinirole prolonged release in Parkinson’s disease
Parkinson’s disease tremor prediction using EEG data analysis-A preliminary and feasibility study
Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease
Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease
Parkinson
Parkinson
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed